Earnings Feed
Sign Up
Home/Filings/4/0001640334-24-000334
4//SEC Filing

EMANUELE ROBERT MARTIN 4

Accession 0001640334-24-000334

CIK 0001621221other
View on SEC.govCompany Profile

Filed

Feb 29, 7:00 PM ET

Accepted

Mar 1, 8:08 PM ET

Size

36.6 KB

Accession

0001640334-24-000334

Insider Transaction Report

Form 4
Period: 2024-02-28
ARTELO BIOSCIENCES, INC.ARTL
EMANUELE ROBERT MARTIN
Director
Transactions
  • Disposition to Issuer

    Stock Option (right to buy)

    2024-02-28−667→ 0 total
    Exercise: $15.00From: 2022-06-23Exp: 2031-07-16→ Common Stock (667 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2024-02-28−667→ 0 total
    Exercise: $1.99Exp: 2033-06-30→ Common Stock (667 underlying)
  • Award

    Stock Option (right to buy)

    2024-02-28+667→ 667 total
    Exercise: $1.55Exp: 2032-06-24→ Common Stock (667 underlying)
  • Award

    Stock Option (right to buy)

    2024-02-28+1,083→ 1,083 total
    Exercise: $1.55Exp: 2033-08-04→ Common Stock (1,083 underlying)
  • Award

    Stock Option (right to buy)

    2024-02-28+834→ 834 total
    Exercise: $1.55Exp: 2028-08-17→ Common Stock (834 underlying)
  • Award

    Stock Option (right to buy)

    2024-02-28+8,034→ 8,034 total
    Exercise: $1.55Exp: 2031-02-12→ Common Stock (8,034 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2024-02-28−8,034→ 0 total
    Exercise: $39.90From: 2023-02-12Exp: 2031-02-12→ Common Stock (8,034 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2024-02-28−667→ 0 total
    Exercise: $4.89From: 2023-06-24Exp: 2032-06-24→ Common Stock (667 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2024-02-28−1,083→ 0 total
    Exercise: $2.01Exp: 2033-08-04→ Common Stock (1,083 underlying)
  • Award

    Stock Option (right to buy)

    2024-02-28+1,167→ 1,167 total
    Exercise: $1.55Exp: 2029-08-29→ Common Stock (1,167 underlying)
  • Award

    Stock Option (right to buy)

    2024-02-28+667→ 667 total
    Exercise: $1.55Exp: 2031-07-16→ Common Stock (667 underlying)
  • Award

    Stock Option (right to buy)

    2024-02-28+667→ 667 total
    Exercise: $1.55Exp: 2033-06-30→ Common Stock (667 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2024-02-28−834→ 0 total
    Exercise: $162.00From: 2021-08-17Exp: 2028-08-17→ Common Stock (834 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2024-02-28−1,167→ 0 total
    Exercise: $29.85From: 2020-02-29Exp: 2029-08-29→ Common Stock (1,167 underlying)
Footnotes (9)
  • [F1]This option was granted on August 17, 2018 and was previously reported as covering 12,500 shares at an exercise price of $10.80 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022.
  • [F2]The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the "Offer") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer).
  • [F3]This option was granted on August 29, 2019 and was previously reported as covering 17,500 shares at an exercise price of $1.99 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022.
  • [F4]This option was granted on February 12, 2021 and was previously reported as covering 120,500 shares at an exercise price of $2.66 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022.
  • [F5]This option was granted on July 16, 2021 and was previously reported as covering 10,000 shares at an exercise price of $1.00 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022.
  • [F6]This option was granted on June 24, 2022 and was previously reported as covering 10,000 shares at an exercise price of $0.326 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022.
  • [F7]Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's 2018 Equity Incentive Plan (the "Plan")) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. "Vesting Commencement Date" shall mean June 30, 2023.
  • [F8]Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. "Vesting Commencement Date" shall mean August 4, 2023.
  • [F9]Pursuant to the Offer, and subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one third (1/3rd) of the shares subject to the option shall vest on the first anniversary of the Amendment Date, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Amendment Date (or, if there is no such day, the last day of the month). "Amendment Date" shall mean February 28, 2024.

Documents

1 file

Issuer

ARTELO BIOSCIENCES, INC.

CIK 0001621221

→
Entity typeother

Related Parties

1
  • filerCIK 0001184991

Filing Metadata

Form type
4
Filed
Feb 29, 7:00 PM ET
Accepted
Mar 1, 8:08 PM ET
Size
36.6 KB
View on SEC.gov